BioSpace News Archive

Genetown

Seismic Therapeutic Announces Presentation of Preclinical Data Demonstrating Advances in Novel Biologics Discovery at the PEGS Boston Summit

Seismic Therapeutic, Inc. today announced the presentation of preclinical data that describe the application of the company’s IMPACT platform at PEGS Boston 2023, taking place on May 15-19.

May 11, 2023
·
3 min read
BioMidwest

Vivek Subbiah, MD, Joins SCRI to Advance Early-Phase Clinical Research

Sarah Cannon Research Institute, one of the world’s leading oncology research organizations conducting clinical trials, is pleased to announce that Vivek Subbiah, MD, has joined the organization as Chief, Early-Phase Drug Development.

May 11, 2023
·
5 min read
BioMidwest

Forge Biologics Announces Eight Presentations at the Upcoming 2023 Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Forge Biologics will be delivered during the upcoming 26th Annual Meeting of the American Society of Gene and Cell Therapy.

May 11, 2023
·
4 min read
Biotech Beach

Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™

Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and testing, announced the integration of OMNIMED™ SmartOR™ across its four locations.

May 11, 2023
·
4 min read
Drug Development

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseasePivotal top-line data readout expected in mid-2023

Bellerophon Therapeutics, Inc. today announced that the last patient has completed blinded treatment in the ongoing Phase 3 REBUILD study of INOpulse®, a proprietary pulsatile nitric oxide delivery system, for the treatment of fibrotic interstitial lung disease (fILD).

May 11, 2023
·
3 min read
Business

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

Comera Life Sciences Holdings, Inc. today reported financial results for the first quarter ended March 31, 2023, and provided a business update.

May 11, 2023
·
9 min read
Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

Femasys Inc. today announced that the Company’s management team will be attending the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM) being held May 19-21, 2023 in Baltimore, Maryland.

May 11, 2023
·
4 min read
Biotech Beach

ChromaDex to Present at the Lytham Partners Spring 2023 Investor Conference

ChromaDex Corp. today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2023 Investor Conference.

May 11, 2023
·
1 min read
Deals

PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) today announces a cash tender offer for up to 7,750,000 shares at $3.25 per share, less any applicable withholding taxes and without interest.

May 11, 2023
·
7 min read
Drug Development

Mirum Pharmaceuticals Announces Enrollment Completion in Phase 2b EMBARK Biliary Atresia Study

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced it has completed enrollment of its Phase 2b EMBARK study for pediatric patients with biliary atresia, the most common indication for pediatric liver transplant.

May 11, 2023
·
7 min read